Article ID Journal Published Year Pages File Type
3352826 Immunity 2015 13 Pages PDF
Abstract

•POP1 inhibits inflammasome-mediated responses to PAMPs and DAMPs•POP1 prevents IL-1β and IL-18 release and pyroptosis•POP1 prevents ASC danger particle-mediated response propagation to bystander cells•Transgenic POP1 expression protects mice from systemic inflammation

SummaryIn response to infections and tissue damage, ASC-containing inflammasome protein complexes are assembled that promote caspase-1 activation, IL-1β and IL-18 processing and release, pyroptosis, and the release of ASC particles. However, excessive or persistent activation of the inflammasome causes inflammatory diseases. Therefore, a well-balanced inflammasome response is crucial for the maintenance of homeostasis. We show that the PYD-only protein POP1 inhibited ASC-dependent inflammasome assembly by preventing inflammasome nucleation, and consequently interfered with caspase-1 activation, IL-1β and IL-18 release, pyroptosis, and the release of ASC particles. There is no mouse ortholog for POP1, but transgenic expression of human POP1 in monocytes, macrophages, and dendritic cells protected mice from systemic inflammation triggered by molecular PAMPs, inflammasome component NLRP3 mutation, and ASC danger particles. POP1 expression was regulated by TLR and IL-1R signaling, and we propose that POP1 provides a regulatory feedback loop that shuts down excessive inflammatory responses and thereby prevents systemic inflammation.

Graphical AbstractFigure optionsDownload full-size imageDownload high-quality image (147 K)Download as PowerPoint slide

Related Topics
Life Sciences Immunology and Microbiology Immunology
Authors
, , , , , , , , , , ,